Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for pain, anxiety, and depression in newly diagnosed breast cancer patients undergoing mastectomy
IRCT20150630022991N14Phase 2Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in major depressive disorder (MDD) and anxiety disorder comparing Escitalopram with Placebo (2 arms). Primary endpoints: Pain severity, Depressive symptoms and 1 more. Started Nov 2018; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on IRCT20150630022991N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150630022991N14.